PositoAI/ US/ BioVie Inc.

BioVie Inc.

NasdaqCM: BIVI · Healthcare

Positivity Index

#2,213 / 6,774

Global

#632 / 4,000

United States

Positivity Score

21,763

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: no active red flags

BioVie Inc. — Overview & Financial Snapshot

BioVie Inc. (NasdaqCM: BIVI) is a Healthcare company, ranked #2,213 of 6,774 companies globally and #632 of 4,000 in United States on PositoAI, with a Positivity Score of 21,763. Its market capitalisation is ₹104.90 Cr ($11.11M), P/E ratio is -0.4 and P/B ratio is 1.08. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#3 Dogwood Therapeutics, Inc. 27,827 #8 Impact BioMedical Inc. 26,149 #13 Onconetix, Inc. 25,902 #15 Revelation Biosciences, Inc. 25,780 #18 Vyome Holdings, Inc. 25,696

— Nothing to show —

OpenAI is reading recent news...

BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 3 for the treatment of life-threatening complications of liver cirrhosis and ascites due to hepatitis, nonalcoholic steatohepatitis, and alcoholism. It also develops Bezisterim, an investigational, novel, orally administered small molecule that is In Phase 3 clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2b clinical trial to treat Parkinson's disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.

P/B Ratio 1.08

P/E Ratio -0.4

D/E Ratio 0.03

ROE -150.76%

Owes vs Owns ? 0.28× Low $0.28 owed for every $1 it owns · balance sheet Jun 2026

Dividend Yield 0.00%

Trailing EPS ₹-287.89$-3.05

Forward EPS ₹-53.80$-0.57

Beta 0.73

Market Cap ₹104.90 Cr$11.11M

What these numbers mean →

What does BioVie Inc. do?

What is BioVie Inc.'s P/E and P/B ratio?

BioVie Inc. has a P/E ratio of -0.4 and a P/B ratio of 1.08.

What is BioVie Inc.'s debt-to-equity ratio?

BioVie Inc. has a debt-to-equity ratio of 0.03.

How much does BioVie Inc. owe compared with what it owns?

BioVie Inc. owes $0.28 for every $1 it owns (balance sheet Jun 2026), which is low.

What is BioVie Inc.'s Positivity rank?

BioVie Inc. is ranked #2,213 of 6,774 companies globally and #632 of 4,000 in United States on PositoAI, with a Positivity Score of 21,763.

Does BioVie Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for BioVie Inc..

Where can I read the latest news about BioVie Inc.?

Recent headlines about BioVie Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does BioVie Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of BioVie Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.